A curated selection of specialized angel investor networks and syndicates that focus on early-stage biotechnology, life sciences, and deep tech ventures. These platforms connect pre-seed founders with experienced backers who understand the long development cycles, regulatory hurdles, and capital intensity inherent in scientific innovation.
Get targeted exposure with custom position pinning and highlighted placement.
Y Combinator's dedicated vertical for biotech and life sciences startups, offering a tailored program that addresses specific needs like IP strategy, clinical trial design, and regulatory compliance. It provides access to a massive alumni network and dedicated life sciences partners who understand the unique path from lab to market.
The leading accelerator for digital health and life sciences startups, providing a comprehensive program that includes funding, mentorship, and a vast network of investors. They specialize in connecting early-stage founders with capital sources interested in both digital therapeutics and broader biotech innovations.
A premier investment network for early-stage life science companies, focusing on connecting founders with angel investors and venture capital firms. They provide deal flow, educational events, and networking opportunities specifically designed for the complexities of biotech fundraising.
While a broad platform, AngelList's 'AngelList Syndicates' feature is critical for biotech founders seeking specialized early funding. It allows accredited investors to pool capital behind lead investors, many of whom have specific tracks in deep tech and life sciences, facilitating efficient pre-seed rounds.
A specialized networking and investment community within the biotech industry, facilitating connections between startups, investors, and industry experts. It offers curated opportunities for pre-seed founders to engage with angel groups that have a deep understanding of scientific validation and pipeline development.
An incubator and networking platform that connects early-stage life science ventures with investors, corporate partners, and academic institutions. It provides a digital interface for startups to showcase their scientific data to angel investors and early-stage VCs interested in transformative biology.
A hub for biotech entrepreneurs in the Mid-Atlantic region that offers networking events, educational resources, and direct introductions to angel investor groups. It helps pre-seed founders navigate the regional ecosystem and connect with investors who are actively deploying capital in early-stage scientific ventures.
One of the largest angel investor networks in the life sciences sector, based in the Boston/Cambridge biotech hub. They focus specifically on early-stage, high-risk/high-reward opportunities, providing critical pre-seed and seed capital from experienced investors who have deep ties to academic research institutions.
A network of experienced investors focused on early-stage biotech, medtech, and digital health companies in the San Diego region. They provide capital and strategic guidance to pre-seed founders, leveraging the dense ecosystem of research hospitals and biotech firms in the area.
An investor network dedicated to supporting early-stage biotech and life sciences startups in Southern California. They organize deal meetings and provide due diligence support, helping pre-seed founders connect with angel investors who understand the local innovation landscape and scientific talent pool.
A network of angel investors focused on life sciences companies in the Pacific Northwest. They provide pre-seed funding and mentorship to startups with strong scientific foundations, connecting founders with investors who have experience in biotechnology, genomics, and pharmaceuticals.
While primarily a conference, it serves as a key networking hub for angel investors and early-stage VCs in the biotech sector. Founders can present to a curated audience of investors interested in pre-seed opportunities, facilitating introductions and discussions on early-stage funding strategies.
A regional biotech ecosystem hub in Cleveland that connects startups with investors, including angel networks and venture capital firms. They offer programmatic support for pre-seed companies, helping them prepare for fundraising and connect with investors who are actively looking for scientific breakthroughs.
Although not exclusively biotech, SFA has a strong track record of investing in life sciences startups originating from local universities and labs. They provide early-stage capital and governance support, connecting founders with investors who are experienced in scaling scientific ventures.
A network that focuses on connecting early-stage biotech companies with angel investors across Europe and the US. They facilitate introductions and provide insights into the funding landscape, helping pre-seed founders identify and engage with investors who specialize in life sciences innovation.
While an accelerator, IndieBio acts as a primary entry point for many pre-seed biotech founders into the angel investor network. They provide upfront funding and lab space, and their strong brand attracts follow-on angel investment from a dedicated community interested in synthetic biology and deep tech.
An incubator that supports early-stage biotech startups with lab space, business mentoring, and investor introductions. They connect founders with a network of angel investors who are specifically interested in supporting the development of novel therapies and biotechnological tools.
An online platform that connects biotech founders with angel investors and institutional capital. It offers a streamlined process for pre-seed fundraising, allowing founders to showcase their scientific data and connect with a global network of investors interested in early-stage life sciences.
A leading early-stage investor network based in Cambridge, UK, with a significant focus on science-based companies. They provide pre-seed and seed funding to biotech startups, leveraging the deep scientific talent and research infrastructure of the Cambridge Biomedical Campus.
A partnership between Innovate UK and various investors to support early-stage life science companies. They offer investment readiness programs and direct connections to angel investors and early-stage funds, helping pre-seed founders navigate the regulatory and commercial challenges of biotech.